Cargando…
TP53 Mutations in Myeloid Malignancies are either Homozygous or Hemizygous due to Copy Number-Neutral Loss of Heterozygosity or Deletion of 17p
Autores principales: | Jasek, Monika, Gondek, Lukasz P., Bejanyan, Nelli, Tiu, Ramon, Huh, Jungwon, Theil, Karl S., O’Keefe, Christine, McDevitt, Michael A., Maciejewski, Jaroslaw P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806506/ https://www.ncbi.nlm.nih.gov/pubmed/19759556 http://dx.doi.org/10.1038/leu.2009.189 |
Ejemplares similares
-
Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021) -
SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD
por: Gondek, Lukasz P., et al.
Publicado: (2007) -
Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort
por: Gambin, Tomasz, et al.
Publicado: (2017) -
VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage
por: Musacchia, Francesco, et al.
Publicado: (2021) -
Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls
por: Simkin, Dina, et al.
Publicado: (2022)